Page last updated: 2024-09-05

methyl 2-((3,4-dihydro-3,4-dioxo-1-naphthalenyl)amino)benzoate and a 63162

methyl 2-((3,4-dihydro-3,4-dioxo-1-naphthalenyl)amino)benzoate has been researched along with a 63162 in 1 studies

Compound Research Comparison

Studies
(methyl 2-((3,4-dihydro-3,4-dioxo-1-naphthalenyl)amino)benzoate)
Trials
(methyl 2-((3,4-dihydro-3,4-dioxo-1-naphthalenyl)amino)benzoate)
Recent Studies (post-2010)
(methyl 2-((3,4-dihydro-3,4-dioxo-1-naphthalenyl)amino)benzoate)
Studies
(a 63162)
Trials
(a 63162)
Recent Studies (post-2010) (a 63162)
16003100

Protein Interaction Comparison

ProteinTaxonomymethyl 2-((3,4-dihydro-3,4-dioxo-1-naphthalenyl)amino)benzoate (IC50)a 63162 (IC50)
Polyunsaturated fatty acid 5-lipoxygenaseRattus norvegicus (Norway rat)0.3475

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cathcart, MK; Folcik, VA1

Other Studies

1 other study(ies) available for methyl 2-((3,4-dihydro-3,4-dioxo-1-naphthalenyl)amino)benzoate and a 63162

ArticleYear
Assessment of 5-lipoxygenase involvement in human monocyte-mediated LDL oxidation.
    Journal of lipid research, 1993, Volume: 34, Issue:1

    Topics: Acetamides; Arachidonate 15-Lipoxygenase; Arachidonate 5-Lipoxygenase; Benzyl Compounds; Humans; Hydroxamic Acids; In Vitro Techniques; Lipoproteins, LDL; Lipoxygenase Inhibitors; Monocytes; Naphthoquinones; ortho-Aminobenzoates; Oxidation-Reduction; Phenyl Ethers

1993